Literature DB >> 26175943

Inhibition of STAT3 reduces proliferation and invasion in salivary gland adenoid cystic carcinoma.

Lin-Lin Bu1, Wei-Wei Deng1, Cong-Fa Huang2, Bing Liu3, Wen-Feng Zhang3, Zhi-Jun Sun1.   

Abstract

In this study, we accessed the expression and correlation of p-STAT3 with Survivin, Cyclin D1, CD147, Slug and Ki67 by immunohistochemical staining of human tissue microarray which contains 72 adenoid cystic carcinoma (AdCC), 12 pleomorphic adenoma (PMA) and 18 normal salivary gland (NSG) using digital pathological scanner and scoring system. We found that the expression of p-STAT3, Survivin, Slug, Cyclin D1 and CD147 was significantly increased in AdCC as compared with PMA and (or) NSG (p<0.05). While, the level of p-STAT3 and expression of Cyclin D1 and CD147 was not associated with pathological type of human AdCC (p>0.05). Correlation analysis of these proteins revealed that p-STAT3 up-regulates the expression of Survivin, Slug, Cyclin D1 and CD147 (p<0.05). Moreover, the activation of STAT3 was associated with proliferation marker Ki-67 (p<0.05). Selective inhibition of STAT3 by a small molecule S3I-201 significantly reduced human SACC-83 and SACC-LM cells proliferation, migration and invasion with the corresponding decrease in expression of Survivin, Slug, Cyclin D1 and CD147. These findings indicate that high phosphorylation level of STAT3 in AdCC is related to Survivin, Slug, Cyclin D1 and CD147. We suggest that the inhibition of STAT3 may be a novel strategy for neoadjuvant chemotherapeutic treatment of AdCC.

Entities:  

Keywords:  CD147; Cyclin D1; S3I-201; STAT3; adenoid cystic carcinoma

Year:  2015        PMID: 26175943      PMCID: PMC4497441     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  30 in total

1.  STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1α.

Authors:  Chi Zhang; Xi Yang; Qu Zhang; Qing Guo; Jia He; Qin Qin; Hongcheng Zhu; Jia Liu; Liangliang Zhan; Jing Lu; Zheming Liu; Liping Xu; Jianxin Ma; Shengbin Dai; Hongyan Cheng; Xinchen Sun
Journal:  Tumour Biol       Date:  2014-07-01

Review 2.  MicroRNA regulation and therapeutic targeting of survivin in cancer.

Authors:  Jingcao Huang; Hui Lyu; Jianxiang Wang; Bolin Liu
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

3.  Inhibition of mTOR reduce Stat3 and PAI related angiogenesis in salivary gland adenoid cystic carcinoma.

Authors:  Guang-Tao Yu; Lin-Lin Bu; Yu-Yue Zhao; Bing Liu; Wen-Feng Zhang; Yi-Fang Zhao; Lu Zhang; Zhi-Jun Sun
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

4.  NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithelial-mesenchymal transition in hepatocellular carcinoma cells.

Authors:  Qi-Da Hu; Wei Chen; Tian-Lian Yan; Tao Ma; Cong-Lin Chen; Chao Liang; Qi Zhang; Xue-Feng Xia; Hao Liu; Xiao Zhi; Xiao-Xiao Zheng; Xue-Li Bai; Xia-Zhen Yu; Ting-Bo Liang
Journal:  Cancer Lett       Date:  2012-07-07       Impact factor: 8.679

5.  Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland.

Authors:  Yongchuan Liao; Hao Zeng; Xiaojie Wang; Ying Huang; Ni Chen; Bo Ge; Li Tang; Qinli Luo
Journal:  Exp Eye Res       Date:  2008-10-09       Impact factor: 3.467

6.  The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling.

Authors:  L Lin; R Amin; G I Gallicano; E Glasgow; W Jogunoori; J M Jessup; M Zasloff; J L Marshall; K Shetty; L Johnson; L Mishra; A R He
Journal:  Oncogene       Date:  2009-01-12       Impact factor: 9.867

7.  Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma.

Authors:  Henry F Frierson; Adel K El-Naggar; John B Welsh; Lisa M Sapinoso; Andrew I Su; Jun Cheng; Takashi Saku; Christopher A Moskaluk; Garret M Hampton
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

8.  Blockage of Stat3 enhances the sensitivity of NSCLC cells to PI3K/mTOR inhibition.

Authors:  Hyeon-Ok Jin; Yun-Han Lee; Jin-Ah Park; Jin-Hee Kim; Sung-Eun Hong; Hyun-Ah Kim; Eun-Kyu Kim; Woo Chul Noh; Byung-Hak Kim; Sang-Kyu Ye; Yoon Hwan Chang; Seok-Il Hong; Young-Joon Hong; In-Chul Park; Jin Kyung Lee
Journal:  Biochem Biophys Res Commun       Date:  2014-01-25       Impact factor: 3.575

9.  Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma.

Authors:  Yohei Mano; Shinichi Aishima; Nobuhiro Fujita; Yuki Tanaka; Yuichiro Kubo; Takashi Motomura; Akinobu Taketomi; Ken Shirabe; Yoshihiko Maehara; Yoshinao Oda
Journal:  Pathobiology       Date:  2013-01-25       Impact factor: 4.342

10.  Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma.

Authors:  Yu-Fan Wang; Wei Zhang; Ke-Fei He; Bing Liu; Lu Zhang; Wen-Feng Zhang; Ashok B Kulkarni; Yi-Fang Zhao; Zhi-Jun Sun
Journal:  Apoptosis       Date:  2014-04       Impact factor: 5.561

View more
  9 in total

1.  PAK2 promotes migration and proliferation of salivary gland adenoid cystic carcinoma.

Authors:  Wei-Wei Deng; Lei Wu; Lin-Lin Bu; Jian-Feng Liu; Yi-Cun Li; Si-Rui Ma; Guang-Tao Yu; Liang Mao; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

2.  B7-H3 regulates migration and invasion in salivary gland adenoid cystic carcinoma via the JAK2/STAT3 signaling pathway.

Authors:  Teng-Fei Fan; Wei-Wei Deng; Lin-Lin Bu; Tian-Fu Wu; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 3.  The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer.

Authors:  Elina Khatoon; Mangala Hegde; Aviral Kumar; Uzini Devi Daimary; Gautam Sethi; Anupam Bishyaee; Ajaikumar B Kunnumakkara
Journal:  Arch Pharm Res       Date:  2022-08-20       Impact factor: 6.010

4.  The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer.

Authors:  Artur A Serebrenik; Prokopios P Argyris; Matthew C Jarvis; William L Brown; Martina Bazzaro; Rachel I Vogel; Britt K Erickson; Sun-Hee Lee; Krista M Goergen; Matthew J Maurer; Ethan P Heinzen; Ann L Oberg; Yajue Huang; Xiaonan Hou; S John Weroha; Scott H Kaufmann; Reuben S Harris
Journal:  Clin Cancer Res       Date:  2020-02-14       Impact factor: 12.531

5.  Endogenous APOBEC3B overexpression characterizes HPV-positive and HPV-negative oral epithelial dysplasias and head and neck cancers.

Authors:  Prokopios P Argyris; Peter E Wilkinson; Matthew C Jarvis; Kelly R Magliocca; Mihir R Patel; Rachel I Vogel; Rajaram Gopalakrishnan; Ioannis G Koutlas; Reuben S Harris
Journal:  Mod Pathol       Date:  2020-07-06       Impact factor: 7.842

6.  AF1q Expression Associates with CD44 and STAT3 and Impairs Overall Survival in Adenoid Cystic Carcinoma of the Head and Neck.

Authors:  Lorenz C Kadletz; Faris F Brkic; Bernhard J Jank; Sven Schneider; Julia Cede; Rudolf Seemann; Elisabeth S Gruber; Elisabeth Gurnhofer; Gregor Heiduschka; Lukas Kenner
Journal:  Pathol Oncol Res       Date:  2019-07-04       Impact factor: 3.201

Review 7.  STAT3 pathway in cancers: Past, present, and future.

Authors:  Han-Qi Wang; Qi-Wen Man; Fang-Yi Huo; Xin Gao; Hao Lin; Su-Ran Li; Jing Wang; Fu-Chuan Su; Lulu Cai; Yi Shi; Bing Liu; Lin-Lin Bu
Journal:  MedComm (2020)       Date:  2022-03-23

8.  Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma.

Authors:  Xing Bao; Tingting Ren; Yi Huang; Shidong Wang; Fan Zhang; Kuisheng Liu; Bingxin Zheng; Wei Guo
Journal:  J Exp Clin Cancer Res       Date:  2016-08-30

9.  A Rabbit Monoclonal Antibody against the Antiviral and Cancer Genomic DNA Mutating Enzyme APOBEC3B.

Authors:  William L Brown; Emily K Law; Prokopios P Argyris; Michael A Carpenter; Rena Levin-Klein; Alison N Ranum; Amy M Molan; Colleen L Forster; Brett D Anderson; Lela Lackey; Reuben S Harris
Journal:  Antibodies (Basel)       Date:  2019-09-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.